Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene

Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene

US Patent 12139709 · Granted Nov 12, 2024

Estimated economic value: $62,076,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligomer compounds2023
Exon skipping oligomer conjugates for muscular dystrophy2022
Exon skipping oligomer conjugates for muscular dystrophy2022
Antisense oligomers and methods of using the same for treating diseases associat2021
Methods and compounds for treatment of lymphocyte-related diseases and condition2021
Antisense-induced exon exclusion in myostatin2021
Exon skipping oligomer conjugates for muscular dystrophy2020
Exon skipping oligomer conjugates for muscular dystrophy2020
Antisense modulation of interleukins 17 and 23 signaling2016